ACRS - Aclaris Therapeutics EPS misses by $0.46 beats on revenue August, 08 2019 04:17 PM Aclaris Therapeutics Inc. Aclaris Therapeutics (NASDAQ:ACRS): Q2 GAAP EPS of -$1.21 misses by $0.46.More news on: Aclaris Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...